| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 616 | 195 | 316 | 31 |
The foci of the journal are Lung cancer, Internal medicine, Oncology, non-small cell lung cancer (NSCLC) and Cancer research. The studies on Lung cancer discussed can also contribute to research in the domains of Cancer, Immunotherapy, Chemotherapy and Bioinformatics. Immunotherapy, which is essential to research in the topics of Immune system and Immunology, is the main topic in Translational lung cancer research.
Translational lung cancer research facilitated presentations on Internal medicine research, particularly Disease, Radiation therapy, Stage (cooking), Adenocarcinoma and Lung. The journal is concerned with the study of Stage (cooking) and Surgery in general. Issues in Lung were discussed, taking into consideration concepts from other disciplines like Radiology and Pathology.
The presented research on Oncology deals specifically with Pembrolizumab but it also addresses topics in Nivolumab. Cancer research research presented in the journal encompasses a variety of subjects, including Epidermal growth factor receptor, Carcinogenesis, Gene, Tyrosine kinase and Anaplastic lymphoma kinase. Epidermal growth factor receptor research presented is mostly focused on the subject of Erlotinib.
The journal papers mostly deal with topics like Lung cancer, Cancer research, Internal medicine, Oncology and Bioinformatics. In addition to Lung cancer research, the published articles aim to explore topics under Cancer, Targeted therapy and Immunotherapy. While the most cited publications focused on Oncology, they were also able to explore topics like Clinical research, Chemotherapy, Liquid biopsy, Disease and Radiation therapy.
The discussions in Translational lung cancer research mainly cover the fields of Lung cancer, Internal medicine, Oncology, non-small cell lung cancer (NSCLC) and Immunotherapy. In addition to Lung cancer research, it aims to explore topics under Cancer, Adenocarcinoma, Cancer research, Chemotherapy and Stage (cooking). Cancer research in Translational lung cancer research involves the investigation of Lung cancer screening studies, all of which are linked to disciplines such as Intensive care medicine.
It addresses concerns in Cancer research which are intertwined with other disciplines, such as Cancer cell and Metastasis. Translational lung cancer research explores issues in Oncology which can be linked to other research areas like Clinical trial, Epidermal growth factor receptor, Targeted therapy, Lung and Biomarker (medicine). In it, Progression-free survival, Adverse effect, Lymph node, KRAS and Proportional hazards model are investigated in conjunction with one another to address concerns in non-small cell lung cancer (NSCLC) research.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Translational lung cancer research (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Translational lung cancer research (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 14.76% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 31.45% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.37% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.43% of all publications and 36.75% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
The expertise and academic background of authors certainly play a crucial role in the depth and validity of the research showcased in any journal. Drawing a closer look at the affiliations and academic background of authors publishing in Translational lung cancer research can offer valuable insights. Many of the authors are associated with leading healthcare and research institutions worldwide.
Contributing authors include registered nurses, medical doctors, research scholars, and even professors from top-rated universalities and colleges. Some authors have their root in best nursing schools in Idaho and are now spearheading cutting-edge research in lung cancer. In fact, a considerable percentage of authors come from a medical background, with specializations in Oncology, Internal Medicine, and Respiratory Medicine.
These affiliations with esteemed institutions and a robust academic background not only bring credibility to the research but can also encourage interdisciplinary collaboration, which is vital in the scientific community. Notably, affiliations also play a critical role in determining the funding, policy impact, and circulation of the research. In a nutshell, the calibre and expertise of the authors reflect the academic rigour that Translational lung cancer research prioritizes.
Sahar Sadat Sedighzadeh;Amin Pastaki Khoshbin;Sepideh Razi;Sepideh Razi;Mahsa Keshavarz-Fathi;Mahsa Keshavarz-Fathi
(2021)David B. Chapel;Jefree J. Schulte;Aliya N. Husain;Thomas Krausz
(2020)Minlin Jiang;Meng Qiao;Chuanliang Zhao;Juan Deng
(2020)Sylvie Lantuejoul;Lynnette Fernandez-Cuesta;Francesca Damiola;Nicolas Girard
(2020)Ku-Geng Huo;Elisa D’Arcangelo;Ming-Sound Tsao
(2020)Yong Song;Chengping Hu;Zhanhong Xie;Lin Wu
(2020)Wenhua Liang;Kaican Cai;Chun Chen;Haiquan Chen
(2020)Joyce W. Y. Chan;Rainbow W. H. Lau;Jenny C. L. Ngai;Carita Tsoi
(2021)Yihui Du;Xiaonan Cui;Grigory Sidorenkov;Harry J. M. Groen
(2020)For those interested in the healthcare field beyond traditional medical school, there are several online degrees and career options that offer flexibility and specialized skills. For instance, individuals curious about the administrative side might explore is medical billing and coding worth it, which highlights the pros and cons of this growing field. Careers in medical billing and coding provide vital support to healthcare providers by managing patient data and insurance claims.
Students seeking formal education in healthcare administration can consider a him degree online. Health Information Management programs focus on organizing and securing patient health information, combining technology with healthcare knowledge, and preparing graduates for roles in hospitals and clinics.
Nutrition also offers promising pathways, especially for those passionate about dietary science and wellness. An online masters degree in nutrition can open doors to careers in dietetics, public health, and clinical nutrition, emphasizing evidence-based dietary interventions and health promotion.
Another specialized healthcare profession gaining popularity is sonography. Prospective students can find accredited sonography programs online that prepare them to operate ultrasound equipment and assist in diagnostic procedures, providing crucial imaging services in medical facilities.
Choosing the right online program depends on career goals, lifestyle, and interests within the medical field. These alternatives offer valuable opportunities to contribute to healthcare without the extended commitment of medical school.
